Inhibrx Biosciences, Inc. (NASDAQ: INBX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT INHIBRX BIOSCIENCES, INC.

Inhibrx Biosciences, Inc. (NASDAQ: INBX)
Listen to this Section


$94.77
-0.5400 ( -0.57% ) 36.3K

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Market Data


Open $94.77
Previous Close $95.31
Volume 36.3K
Market Cap $1.40B
Day Range $92.49 - $96.21
52 Week Range $13.97 - $155.29
Shares Outstanding 14.67M
Change % -0.57%
Net Change ▼ -0.5400
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2024
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 74,985.00

Date Type Amount Purchased Purchaser
2024-11-22 Buy 34843.00 Kayyem Jon Faiz
2024-10-07 Buy 6667.00 Vuori Kristiina MD
2024-09-16 Buy 26963.00 Lappe Mark
2024-09-12 Buy 179.00 Vuori Kristiina MD
2024-09-10 Buy 26000.00 Lappe Mark
2024-09-03 Buy 7140.00 Vuori Kristiina MD
2024-09-03 Buy 10000.00 Lappe Mark
2024-08-30 Buy 10000.00 MANHARD KIMBERLY
2024-08-26 Buy 15188.00 FORSYTH DOUGLAS
2024-08-22 Buy 27055.00 Lappe Mark

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 66 Nov 14, 2025
8-k 8K-related 14 Nov 14, 2025
8-k 8K-related 50 Oct 23, 2025
4 Insider transactions 1 Oct 09, 2025
10-q Quarterly Reports 68 Aug 13, 2025
8-k 8K-related 14 Aug 13, 2025

Latest News